Mutations in the glucose-6-phosphatase catalytic subunit 1 (G6PC1) gene lead to deficiency of the G6Pase enzyme, preventing the release of stored glycogen or endogenous glucose production
In the 1990s, as the obesity pandemic spreads, even young people start to lose their ability to keep their body weight and blood glucose in balance
Now, if you're comparing tirzepatide vs semaglutide weight loss, note that both show strong results
The phase 1b, 16-week, multiple-dose ascending trial (NCT05613387) showed a mean body weight reduction of 4.8%, 8.6% and 8.3% at OW doses of up to 2.4 mg, 4.8 mg and 9.0 mg, respectively [116]
Third-Party Testing: Supplements can get sketchy, especially considering theyre not regulated like other products out there